Financial statements Frexemed
Cash flow statement of Frexemed
Company age:
Age:
4 y. 6 m. 1 d.
Share capital:
Share capital:
5 000 PLN
Cash inflows of FREXEMED
|
Year
|
2021
|
2022
|
2023
|
|---|---|---|---|
| Net cash from operating expenses | -1 282,02 | -144,00 | -293 187,69 |
| Net cash flow from investing activities | 0,00 | 0,00 | -418,00 |
| Net cash flow from financial activities | 5 000,00 | 0,00 | 365 000,00 |
| Total net cash flow | 3 717,98 | -144,00 | 71 394,31 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.